BWA
DNA icon

Basecamp Wealth Advisors’s Ginkgo Bioworks DNA Stock Holding History

Basecamp Wealth Advisors’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149 Sell
15
-26
-63% -$217 ﹤0.01% 1757
2026
Q1 		$251 Sell
41
-31
-43% -$258 ﹤0.01% 1839
2025
Q4 		$598 Buy
+72
New +$775 ﹤0.01% 1591

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Basecamp Wealth Advisors's DNA Position: Q2 2026 in Review

Basecamp Wealth Advisors reduced its Ginkgo Bioworks (DNA) stake by 63% in Q2 2026, selling an estimated $217 and leaving 15 shares worth $149. The position accounts for ﹤0.01% of the portfolio, ranked #1757.

Basecamp Wealth Advisors first reported a position in DNA in Q4 2025 and has held it in 3 quarters since. The position peaked at $598 in Q4 2025. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Basecamp Wealth Advisors held 15 shares of Ginkgo Bioworks worth $149 as of Q2 2026.
  • Basecamp Wealth Advisors sold 26 Ginkgo Bioworks shares in Q2 2026, an estimated $217.
  • Ginkgo Bioworks made up ﹤0.01% of Basecamp Wealth Advisors's portfolio in Q2 2026, its #1757 holding.
  • Basecamp Wealth Advisors first reported a position in Ginkgo Bioworks in Q4 2025 and has held it in 3 quarters since.
  • Basecamp Wealth Advisors's Ginkgo Bioworks position peaked at $598 in Q4 2025.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Basecamp Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.